Literature DB >> 24912612

The diagnostic value of one-step nucleic acid amplification (OSNA) for sentinel lymph nodes in colon cancer patients.

F J Vogelaar1, M S Reimers, R L A van der Linden, J C van der Linden, V T H B M Smit, D J Lips, C J H van de Velde, K Bosscha.   

Abstract

BACKGROUND: Lymph node status in colon cancer is critical for prognosis estimation and treatment allocation. The purpose of this study was to compare the performance of one-step nucleic acid amplification (OSNA) through detection of cytokeratin 19 mRNA levels with routine pathological examination (RP) and multilevel fine pathological examination (FP) in sentinel lymph nodes (SLN), detected using the ex vivo SLN mapping (SLNM) procedure, in presurgically defined nonmetastatic colon cancer patients.
METHODS: In this prospective study, 325 SLNs of 128 patients from the Jeroen Bosch Hospital in 's-Hertogenbosch and the Leiden University Medical Center were investigated by RP (H&E), FP (H&E and Keratin Pan immunohistochemical staining), and OSNA. The SLNs were harvested by the SLNM procedure, using Patent blue or Indocyanine green. SLNs were divided and separate parts were used for RP, FP, and the OSNA assay.
RESULTS: The diagnostic value of OSNA was 82.1 and 100 % for both FP and combined method (OSNA and FP) compared with RP. An upstaging rate of 20.2 % was obtained with the use of OSNA only and 36.4 % with the use of FP only. An upstaging rate of 46.5 % was obtained by combining the two methods together.
CONCLUSIONS: OSNA and FP appeared to be promising tools for the detection of lymph node micro- and macrometastases in SLNs after SLNM. The performances of OSNA and FP in this study were superior to RP. Because OSNA allows analysis of the whole lymph node, sampling bias can be avoided. OSNA therefore may improve tumor staging.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24912612     DOI: 10.1245/s10434-014-3820-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  14 in total

Review 1.  Management of nodal disease from colon cancer in the laparoscopic era.

Authors:  Corrado Pedrazzani; Lelde Lauka; Simone Sforza; Andrea Ruzzenente; Filippo Nifosì; GianGaetano Delaini; Alfredo Guglielmi
Journal:  Int J Colorectal Dis       Date:  2014-11-22       Impact factor: 2.571

2.  Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial.

Authors:  Benjamin Weixler; Andreas Rickenbacher; Dimitri Aristotle Raptis; Carsten T Viehl; Ulrich Guller; Jessica Rueff; Andreas Zettl; Markus Zuber
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

Review 3.  Is it time for one-step nucleic acid amplification (OSNA) in colorectal cancer? A systematic review and meta-analysis.

Authors:  J B Wild; N Iqbal; J Francombe; T Papettas; D S Sanders; S Ramcharan
Journal:  Tech Coloproctol       Date:  2017-09-08       Impact factor: 3.781

Review 4.  Assessment of lymph node involvement in colorectal cancer.

Authors:  Mark L H Ong; John B Schofield
Journal:  World J Gastrointest Surg       Date:  2016-03-27

5.  One-step nucleic acid amplification analysis of sentinel lymph nodes in papillary thyroid cancer patients.

Authors:  Krzysztof A Kaczka; Lech Pomorski
Journal:  Arch Med Sci       Date:  2017-01-25       Impact factor: 3.318

6.  Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma.

Authors:  Natalia Rakislova; Carla Montironi; Iban Aldecoa; Eva Fernandez; Josep Antoni Bombi; Mireya Jimeno; Francesc Balaguer; Maria Pellise; Antoni Castells; Miriam Cuatrecasas
Journal:  J Transl Med       Date:  2017-01-14       Impact factor: 5.531

7.  Elucidation of inhibitory effects on metastatic sentinel lymph nodes of breast cancer during One-Step Nucleic Acid Amplification.

Authors:  Yoshiya Horimoto; Masahiko Tanabe; Saiko Kazuno; Yoshiki Miura; Kaoru Mogushi; Hiroshi Sonoue; Atsushi Arakawa; Kazunori Kajino; Toshiyuki Kobayashi; Mitsue Saito
Journal:  Sci Rep       Date:  2018-05-15       Impact factor: 4.379

8.  Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma.

Authors:  Sherley Diaz-Mercedes; Ivan Archilla; Jordi Camps; Antonio de Lacy; Iñigo Gorostiaga; Dulce Momblan; Ainitze Ibarzabal; Joan Maurel; Nuria Chic; Josep Antoni Bombí; Francesc Balaguer; Antoni Castells; Iban Aldecoa; Josep Maria Borras; Miriam Cuatrecasas
Journal:  Appl Health Econ Health Policy       Date:  2019-10       Impact factor: 2.561

9.  Prognostic Significance of Lymph Node Examination by the OSNA Method in Lung Cancer Patients-Comparison with the Standard Histopathological Procedure.

Authors:  Josef Vodicka; Martin Pesta; Vlastimil Kulda; Katerina Houfkova; Bohuslava Vankova; Jakub Sebek; Martin Skala; Jakub Fichtl; Kristyna Prochazkova; Ondrej Topolcan
Journal:  Cells       Date:  2020-12-04       Impact factor: 6.600

10.  Molecularly determined total tumour load in lymph nodes of stage I-II colon cancer patients correlates with high-risk factors. A multicentre prospective study.

Authors:  Iban Aldecoa; Begoña Atares; Jordi Tarragona; Laia Bernet; Jose Domingo Sardon; Teresa Pereda; Carlos Villar; M Carmen Mendez; Elvira Gonzalez-Obeso; Kepa Elorriaga; Guadalupe Lopez Alonso; Javier Zamora; Nuria Planell; Jose Palacios; Antoni Castells; Xavier Matias-Guiu; Miriam Cuatrecasas
Journal:  Virchows Arch       Date:  2016-07-22       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.